These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3298656)

  • 1. C4 nephritic factor in a patient with chronic glomerulonephritis.
    Fujita T; Sumita T; Yoshida S; Ito S; Tamura N
    J Clin Lab Immunol; 1987 Feb; 22(2):65-70. PubMed ID: 3298656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus transformed B cell lines derived from patients with systemic lupus erythematosus produce a nephritic factor of the classical complement pathway.
    Hiramatsu M; Tsokos GC
    Clin Immunol Immunopathol; 1988 Jan; 46(1):91-9. PubMed ID: 2826058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of C4 nephritic factor by an enzyme-linked immunosorbent assay.
    Seino J; Kinoshita Y; Sudo K; Horigome I; Sato H; Narita M; Noshiro H; Kudo K; Fukuda K; Saito T
    J Immunol Methods; 1990 Mar; 128(1):101-8. PubMed ID: 2324500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
    Blom AM; Corvillo F; Magda M; Stasiłojć G; Nozal P; Pérez-Valdivia MÁ; Cabello-Chaves V; Rodríguez de Córdoba S; López-Trascasa M; Okrój M
    J Clin Immunol; 2016 Jul; 36(5):517-27. PubMed ID: 27146825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.
    Garam N; Prohászka Z; Szilágyi Á; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik-Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Romana Rysava ; Reiterova J; Saraga M; Tomáš Seeman ; Zieg J; Sládková E; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Csuka D
    Orphanet J Rare Dis; 2019 Nov; 14(1):247. PubMed ID: 31703608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
    Berthoux FC; Freyria AM
    Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
    Ohi H; Yasugi T
    Clin Exp Immunol; 1994 Feb; 95(2):316-21. PubMed ID: 8306508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF; Richards NP; Powell RJ; Morgan AG
    Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of C3d in primitive chronic glomerular nephritis (author's transl)].
    Lagrue G; Branellec A; Intrator L; Moisy M; Sobel A
    Nephrologie; 1980; 1(1):20-2. PubMed ID: 6975443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in acute glomerulonephritis in children.
    Levy M; Sich M; Pirotzky E; Habib R
    Int J Pediatr Nephrol; 1985; 6(1):17-24. PubMed ID: 3997368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serum C3-activating factor: its characterization and its presence in glomerular deposits.
    Roberts JL; Levy M; Chioros PG; Bartlow BG; Forristal J; West CD; Habib R; Lewis EJ
    J Immunol; 1981 Sep; 127(3):1131-7. PubMed ID: 7021675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hemolytic method for the measurement of nephritic factor.
    West CD
    J Immunol Methods; 2008 Jun; 335(1-2):1-7. PubMed ID: 18410942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood level of C3 complement component as an aid in the management of acute phase glomerulonephritis.
    Friedman R; Benderly A; Golan D; Levy J; Etzioni A
    Isr J Med Sci; 1985 Feb; 21(2):118-22. PubMed ID: 3980189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation by circulating serum factors in human glomerulonephritis.
    Meri S
    Clin Exp Immunol; 1985 Feb; 59(2):276-84. PubMed ID: 3919977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated decay of the cell bound C4b2a complex by serum of patients with membranoproliferative glomerulonephritis and acute poststreptococcal glomerulonephritis.
    Tanuma Y; Ohi H; Hatano M
    Clin Immunol Immunopathol; 1992 Mar; 62(3):270-6. PubMed ID: 1541053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in glomerulonephritis.
    Baer D
    N Engl J Med; 1977 Jun; 296(22):1299. PubMed ID: 859526
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.